로딩 중…
지수 로딩 중…
Humedix
200670· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩26,850-2.36%
2026-06-19
Price Chart
Humedix-54.95%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 301.52B KRW |
| Revenue | 170.43B KRW |
| Net Income | 51.35B KRW |
| Total Assets | 338.44B KRW |
| Net Assets | 310.60B KRW |
| Employees | 371 |
| Value | |
| P/E | 5.87x |
| P/B | 0.97x |
| P/S | 1.77x |
| EV/EBITDA | 6.32x |
| FCF Yield | 12.34% |
| Profitability | |
| ROE | 16.53% |
| ROA | 15.17% |
| Op. Margin | 23.36% |
| Revenue Growth | 0.95% |
| Earnings Growth | -3.23% |
| Financial Health | |
| Debt Ratio | 108.96% |
| Total Debt | 0 KRW |
| FCF | 37.21B KRW |
| Cash | 50.10B KRW |
| Current Ratio | 8.03x |
| Net Debt/EBITDA | -1.26x |
| Dividend | |
| Div. Yield | 3.35% |
| Div. Growth | 46.03% |
| Performance | |
| 1Y Return | -54.95% |
| 1M Return | -6.45% |
| From 52W High | -65.22% |
| 1Y MDD | -67.81% |
| Trading | |
| Volume | 55,695 shares |
| Foreign Own. | 8.21% |
| Per Share | |
| EPS | 4,573 KRW |
| BPS | 27,986 KRW |
Company Info
Humedix, established in 2003 for the manufacturing and sale of functional foods, changed its name from its original in 2010 and was listed on KOSDAQ in 2014. Through research and development of hyaluronic acid and PDRN, the company produces and supplies fillers, botulinum toxin, arthritis therapeutics, and cosmetics to domestic and international healthcare markets. Humedix strengthens its market presence by acquiring European CE and Chinese NMPA certifications for its proprietary HI method fillers. It maximizes synergy through heparin sodium localization and an aesthetic solution portfolio, and is headquartered in Seongnam-si, Gyeonggi-do.